Psoriasis

Psoriasis has a substantial psychological burden that affects quality of life for many patients, according to a presentation at the European Academy of Dermatology and Venereology virtual congress.

Healio Psoriatic Disease, the first publication focused on informing health care professionals about the burden of psoriatic disease and the understanding of psoriasis as a systemic disease, has named Joel M. Gelfand, MD, MSCE, as its Chief Medical Editor.

Treatment of psoriatic conditions or Crohn’s disease with ustekinumab was associated with severe cardiovascular events in certain high-risk patients, according to a study.

A psoriatic microenvironment score could help predict how some psoriatic lesions will respond to certain treatments, allowing practitioners to reduce exposure to ineffective therapies, according to a study.

In approximately one-third of cases, psoriasis begins in pediatric patients, according to the American Academy of Dermatology.

Despite dramatic advances in our therapeutic armamentarium for managing psoriasis with pills and biologics, topical therapies remain the most commonly used arrow in our therapeutic quiver.

The association between psoriatic disease and cardiovascular disease has been known for the past decade, but new research aims to determine if long-term psoriasis treatment affects heart health.

Patients with psoriasis, as well as their family members, experience multiple negative impacts to their quality of life due to the disease, according to a poster presented at the American Academy of Dermatology virtual meeting.

Coronary artery plaque lipid-rich necrotic core was associated with psoriasis severity and may be improved with biologic therapy, researchers reported.

Many dermatologists prescribe topical antifungals for the treatment of inverse psoriasis, according to a survey study presented at the AAD VMX virtual meeting.